PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
7116.67%
Some net income increase while CRK is negative at -23.75%. John Neff would see a short-term edge over the struggling competitor.
-4.81%
Both reduce yoy D&A, with CRK at -60.07%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
404.35%
Some yoy growth while CRK is negative at -11.63%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-522.22%
Both cut yoy SBC, with CRK at -13.91%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
293.02%
Well above CRK's 70.20% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
275.36%
AR growth well above CRK's 220.17%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
293.02%
Some yoy usage while CRK is negative at -137.86%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-292.59%
Negative yoy while CRK is 94.14%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-22.47%
Both yoy CFO lines are negative, with CRK at -10.87%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-37.63%
Negative yoy CapEx while CRK is 19.41%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-76.19%
Negative yoy acquisition while CRK stands at 100.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
442.11%
We have some outflow growth while CRK is negative at -100.00%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-10.83%
We reduce yoy invests while CRK stands at 19.36%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-428.57%
Both yoy lines negative, with CRK at -280.00%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.